World's Best Scientists 2026 revealed!
Fumitaka Suzuki

Fumitaka Suzuki

Award Badge
Microbiology
Taiwan
2025

D-Index & Metrics

Microbiology

D-Index
73
Citations
17991
World Ranking
1675
National Ranking
45

Medicine

D-Index
74
Citations
19088
World Ranking
19432
National Ranking
624

Fumitaka Suzuki publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Fumitaka Suzuki sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 403 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Fumitaka Suzuki D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Fumitaka Suzuki sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 73 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Microbiology in Taiwan Leader Award
  • 2022 - Research.com Microbiology in Taiwan Leader Award

Overview

Fumitaka Suzuki is affiliated with National Taiwan University in Taiwan and has an extensive publication record predominantly within the field of Medicine. Their research primarily focuses on hepatology, epidemiology, and oncology, with a considerable portion of studies related to liver disease diagnosis and treatment, hepatocellular carcinoma, and viral hepatitis.

Their recent significant papers include:

  • Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma, 2020, Liver Cancer
  • Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy, 2022, Journal of Hepatology
  • SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology, 2020, Internal Medicine
  • Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis, 2020, Liver Cancer
  • Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up study, 2022, Hepatology Communications

Fumitaka Suzuki frequently collaborates with multiple coauthors, including:

  • Hiromitsu Kumada
  • Tetsuya Hosaka
  • Yusuke Kawamura
  • Norio Akuta
  • Yoshiyuki Suzuki

The scientist's work is regularly published in specific venues, reflecting their research scope. These publication venues include:

  • Hepatology Research
  • Oncology
  • Internal Medicine
  • Clinical Journal of Gastroenterology
  • Journal of Hepatology

Within the broader field of Medicine, Suzuki has contributed extensively to subfields as outlined below:

  • Hepatology
  • Epidemiology
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Surgery

Key research topics addressed by Suzuki focus on the following areas:

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Liver Disease and Transplantation
  • Diet, Metabolism, and Disease
  • MRI in cancer diagnosis

Best Publications

  • Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

    Tetsuya Hosaka;Fumitaka Suzuki;Masahiro Kobayashi;Yuya Seko

  • Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus–related liver cancer

    Kenji Ikeda;Yasuji Arase;Satoshi Saitoh;Masahiro Kobayashi

  • Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

    Norio Akuta;Fumitaka Suzuki;Miharu Hirakawa;Yusuke Kawamura

  • Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

    Yasuji Arase;Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta

  • Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.

    Yusuke Kawamura;Yasuji Arase;Kenji Ikeda;Yuya Seko

  • Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options.

    Yoshiyuki Suzuki;Kenji Ikeda;Fumitaka Suzuki;Joji Toyota

  • Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis

    Yee Hui Yeo;Hsiu J. Ho;Hwai I. Yang;Tai Chung Tseng

  • Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis

    Unknown

  • Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

    Yasuji Arase;Mariko Kobayashi;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Correlation between serum hepatitis B virus core‐related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients

    Fumitaka Suzuki;Hideo Miyakoshi;Mariko Kobayashi;Hiromitsu Kumada

  • Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir.

    Yoshiyasu Karino;Joji Toyota;Kenji Ikeda;Fumitaka Suzuki

  • Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients

    Atsushi Ono;Fumitaka Suzuki;Yusuke Kawamura;Hitomi Sezaki

  • Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis.

    Hiromitsu Kumada;Kazuaki Chayama;Lino Rodrigues;Fumitaka Suzuki

  • Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis

    Tsunehisa Kawasaki;Akihiro Takeshita;Kenichi Souda;Yoshimasa Kobayashi

  • Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B

    Yasuji Arase;Kenji Ikeda;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C

    Yusuke Kawamura;Kenji Ikeda;Yasuji Arase;Hiromi Yatsuji

  • Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.

    Yoshiyuki Suzuki;Mariko Kobayashi;Kenji Ikeda;Fumitaka Suzuki

  • Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

    Kazuaki Chayama;C. Nelson Hayes;Hiromi Abe;Daiki Miki

  • The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment

    Norio Akuta;Fumitaka Suzuki;Mariko Kobayashi;Akihito Tsubota

Frequent Co-Authors

Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Kenji Ikeda
Kenji Ikeda University of California, San Francisco
Yoshiyuki Suzuki
Yoshiyuki Suzuki Fukushima Medical University
Yasuji Arase
Yasuji Arase University of Yamanashi
Masahiro Kobayashi
Masahiro Kobayashi Toranomon Hospital
Tetsuya Hosaka
Tetsuya Hosaka Toranomon Hospital
Hitomi Sezaki
Hitomi Sezaki Toranomon Hospital
Satoshi Saitoh
Satoshi Saitoh Toranomon Hospital
Mariko Kobayashi
Mariko Kobayashi Kaohsiung Medical University
Kazuaki Chayama
Kazuaki Chayama Hiroshima University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open up a variety of career opportunities. Many aspiring healthcare professionals consider medical programs online, which offer flexible learning paths while maintaining rigorous standards. These programs often serve as a foundation for specialized scientific and clinical roles.

Public health is another closely related field, with numerous institutions offering some of the best easiest mph online programs to get into. Pursuing a Master of Public Health (MPH) complements microbiology by focusing on disease prevention, epidemiology, and community health initiatives.

For those interested in therapeutic and support roles, becoming certified as a Child Life Specialist is a rewarding pathway. Learning more about ccls certification can guide microbiology graduates toward careers in child-focused healthcare settings.

Importantly, online education has become more accessible for diverse populations, including those with previous convictions. Resources highlighting online degrees for felons emphasize inclusive opportunities that help many students pursue science and health-related careers without barriers.

Best Scientists Citing Fumitaka Suzuki

Trending Scientists

Recently Published Articles